Journal
BIOLOGICAL CHEMISTRY
Volume 394, Issue 4, Pages 471-477Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/hsz-2012-0335
Keywords
innate immunity; myeloid cell; oxygen sensing; prolyl hydroxylase domain-containing enzymes (PHDs)
Categories
Funding
- Medical Research Council [G0802255]
- Wellcome Trust [078244, 098516]
- MRC [G0802255] Funding Source: UKRI
- Medical Research Council [G0802255] Funding Source: researchfish
- National Institute for Health Research [ACF-2006-04-005, CL-2012-04-001] Funding Source: researchfish
Ask authors/readers for more resources
Many inflammatory diseases are characterised by persistent and inappropriate neutrophil activation, systemic or localised hypoxia, and bacterial colonisation. Hypoxia represents an important regulator of inflammatory responses because it inhibits neutrophil apoptosis, a process central to the timely resolution of inflammation. Progress in understanding how cells respond to hypoxia has led to the identification of hypoxia-inducible transcription factors (HIFs) and their hydroxylation by the prolyl hydroxylase enzymes. There is now a significant body of data to support a critical role for this HIF pathway in regulating neutrophil function. Moreover, manipulations of specific components of this pathway have very divergent effects on myeloid cell function. In this review, we will discuss the role individual members of the HIF pathway play in regulating key neutrophil functions and the implications this has for the development of effective therapeutic strategies that selectively target inappropriate neutrophil persistence while maintaining a fully competent immune response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available